Table 1.
Patient Number | Envelope | Macrophage Infectivity (%)a | Patient Number | Envelope | Macrophage Infectivity (%)a |
NA20 | B59 | 16.9b | P1114 | C95-65 | 0.029 |
B76 | 0.179 | C96-26 | 0.097 | ||
B501 | 51.6 | C98-15 | 32.4 | ||
LN3 | <0.001 | C98-18 | 2.21 | ||
LN8 | <0.001 | C98-27 | 0.144 | ||
LN10 | 0.030 | C98-28 | 0.004 | ||
LN14 | 0.025 | C98-67 | 0.003 | ||
LN16 | 0.036 | P3 | Q3 164 1.4 | 0.002 | |
NA420 | B13 | 0.335 | Q3 180 6.4 | 0.003 | |
B33 | 3.35 | SQ3 196 10.1 | 0.012 | ||
B42 | 0.559 | SQ3 197 9.3 | 0.338 | ||
LN40 | 0.009 | SQ3 199 8.5 | 0.003 | ||
LN85 | 0.026 | P31 | Q31 350.1 | 0.05 | |
NA118 | B12 | 0.006 | Q31 351.6 | 0.02 | |
LN27 | 0.023 | SQ31 308.2 | 0.02 | ||
LN33 | 0.023 | P43 | Q43 378.2 | 0.03 | |
NA176 | B93 | 8.2 | SQ43 380.1 | 0.6 | |
NA353 | B27 | 12.6 | SQ43 380.4 | 9.63 | |
Controls | AD8 | 4.60 | |||
SF162 | 6.25 | ||||
YU2 | 6.36 | ||||
JRFL | 3.27 | ||||
JRCSF | 0.011 |
aMacrophage infectivity as a percent of infectivity recorded on HeLa TZM-BL cells. Most of this data is derived from that presented in Peters et al. [27] with the addition of SQ43 380.4.
bBolded percentages indicate envelopes that were designated as macrophage-tropic i.e. >0.5% of infectivity for HeLa TZM-BL cells.